KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Dividends payables (2016 - 2025)

Historic Dividends payables for Eli Lilly (LLY) over the last 17 years, with Q2 2025 value amounting to $1.3 billion.

  • Eli Lilly's Dividends payables rose 1492.52% to $1.3 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 billion, marking a year-over-year increase of 1492.52%. This contributed to the annual value of $1.3 billion for FY2024, which is 1514.71% up from last year.
  • Latest data reveals that Eli Lilly reported Dividends payables of $1.3 billion as of Q2 2025, which was up 1492.52% from $1.3 billion recorded in Q4 2024.
  • Eli Lilly's Dividends payables' 5-year high stood at $1.3 billion during Q4 2024, with a 5-year trough of $770.8 million in Q2 2021.
  • Moreover, its 5-year median value for Dividends payables was $1.0 billion (2022), whereas its average is $1.1 billion.
  • Its Dividends payables has fluctuated over the past 5 years, first skyrocketed by 1445.25% in 2022, then soared by 1518.93% in 2023.
  • Eli Lilly's Dividends payables (Quarter) stood at $885.5 million in 2021, then rose by 14.87% to $1.0 billion in 2022, then grew by 14.94% to $1.2 billion in 2023, then rose by 15.15% to $1.3 billion in 2024, then decreased by 0.08% to $1.3 billion in 2025.
  • Its Dividends payables stands at $1.3 billion for Q2 2025, versus $1.3 billion for Q4 2024 and $1.2 billion for Q2 2024.